Related Experiment Video
Updated: Mar 10, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
A peptide-based synthetic transcription factor selectively down-regulates the proto-oncogene CFOS in tumour cells and
Madhumita Chakraborty1, Siddhartha Roy1
1Department of Biophysics, Bose Institute, P-1/12 CIT Scheme VII M, Kolkata 700054, India. sidroykolkata@gmail.com.
Abstract:
Selectively regulating genes is an important goal in Chemical Biology. We report the development of a peptide-based synthetic transcription factor which binds the targeted DNA sequence with high affinity and single base-pair discrimination capability. When delivered inside a tumor cell, it regulated targeted genes selectively and inhibited cell proliferation.
Insights
Scientists created a synthetic transcription factor using peptides. This molecule precisely controls gene activity in tumor cells, stopping their growth.
Area of Science:
- Chemical Biology
- Molecular Biology
- Synthetic Biology
Background:
- Precise control over gene expression is crucial in chemical biology.
- Developing tools for targeted gene regulation remains a significant challenge.
Purpose of the Study:
- To engineer a novel peptide-based synthetic transcription factor.
- To achieve high-affinity DNA binding with single base-pair specificity.
- To demonstrate selective gene regulation and inhibition of cancer cell proliferation.
Main Methods:
- Design and synthesis of a peptide-based transcription factor.
- Assay of DNA binding affinity and specificity.
- Delivery of the synthetic transcription factor into tumor cells.
- Analysis of targeted gene expression and cell proliferation.
Main Results:
- The synthetic transcription factor exhibited high-affinity binding to target DNA sequences.
- It demonstrated precise discrimination at the single base-pair level.
- Intracellular delivery led to selective regulation of targeted genes.
- Significant inhibition of tumor cell proliferation was observed.
Conclusions:
- A novel peptide-based synthetic transcription factor was successfully developed.
- This tool offers precise control over gene expression with high specificity.
- The findings highlight potential therapeutic applications in cancer treatment.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
05:44The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo
Published on: April 25, 2016
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Transcription Factors
Co-activators and Co-repressors